RADIOIODINATED CONJUGATES FOR THERAPY AND DIAGNOSIS

Information

• Research Project
• 3614215

• ApplicationId

  3614215

• Core Project Number

  N44CM067759

• Full Project Number

  N44CM067759-001

• Serial Number

  67759

• FOA Number

• Sub Project Id

• Project Start Date

  9/30/1986 - 38 years ago

• Project End Date

  9/29/1988 - 36 years ago

• Program Officer Name

• Budget Start Date

  6/30/1987 - 37 years ago

• Budget End Date

  9/29/1988 - 36 years ago

• Fiscal Year

  1987

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• NEORX CORPORATION

The contractor shall optimize the radioiodination reactions and test several difference radioiodinated conjugates for in vitro and in vivo stability. A comparison of a conventional (directly) radioiodinated antibody with the same antibody labeled using the radioiodinated conjugates, will be carried out. Studies using an iodine-131 labeled antibody will be conducted (in nude rats) to measure tissue dosimetry. The untimate goal of the study is to identify n antibody and a radioiodine conjugate that can become a commercial cancer therapy agent.

IC Name

• Activity

  N44

• Administering IC

  CM

• Application Type

  5

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

• Sub Project Total Cost

• ARRA Funded

• CFDA Code

  395

• Ed Inst. Type

• Funding ICs

• Funding Mechanism

• Study Section

• Study Section Name

• Organization Name

  NEORX CORPORATION

• Organization Department

• Organization DUNS

• Organization City

  SEATTLE

• Organization State

  WA

• Organization Country

  UNITED STATES

• Organization Zip Code

  98119

• Organization District

  UNITED STATES